Abstract 4468: A novel sulindac derivative (MDC-922) inhibits the growth of human colon cancer cell lines: A redox/polyamine-dependent effect
Year: 2010
Type: conference-abstract
Source: Cancer Research
Institutions: Stony Brook University, Stony Brook Medicine
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2067482802
